Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic

Journal of Cachexia, Sarcopenia and Muscle

Volumn , Issue , 2015, Pages 95-98

  Dev, Rony ^a   Hui, David ^a   Chisholm, Gary ^a   Delgado Guay, Marvin ^a   Dalal, Shalini ^a   Del Fabbro, Egidio ^b   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Advanced cancer; Cachexia; Hypermetabolism; Palliative care; Symptoms

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ADVANCED CANCER; ANOREXIA; ANXIETY; ARTICLE; CACHEXIA; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUCASIAN; COMPARATIVE STUDY; DIGESTIVE SYSTEM CANCER; EDMONTON SYMPTOM ASSESSMENT SCORE; FEMALE; FEMALE GENITAL TRACT CANCER; GROUPS BY AGE; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERMETABOLISM; INDIRECT CALORIMETRY; INSOMNIA; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; RESTING ENERGY EXPENDITURE; RETROSPECTIVE STUDY; SARCOMA; SEX DIFFERENCE; SKIN CANCER; SOLID TUMOR; STATISTICS; SURVIVAL TIME; SYMPTOM ASSESSMENT; THORAX TUMOR; UROGENITAL TRACT CANCER; WEIGHT REDUCTION;

EID: 84941631425     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12014     Document Type: Article

References (19)

1. Dunlop R. Clinical epidemiology of cancer cachexia, In Bruera E, Higginson I (eds). Cachexia-Anorexia in Cancer Patients. Oxford: United Kingdom, Oxford University Press; 1996. 76–82.
2. Tchekmedyian NS. Costs and benefits of nutrition support in cancer. Oncology (Huntingt) 1995; 9: 79–84.
3. Esper DH, Harb WA. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract 2005; 20: 369–376.
4. Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F. Therapy insight: cancer anorexia-cachexia syndrome – when all you can eat is yourself. Nat Clin Pract Oncol 2005; 2: 158–165.
5. Chioléro R, Revelly JP, Tappy L. Energy metabolism in sepsis and injury. Nutrition 1997; 13: 45S–51S.
6. Del Fabbro E, Hui D, Dalal S, Dev R, Nooruddin ZI, Bruera E. Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med 2011; 14: 1004–1008.
7. Bosaeus I, Daneryd P, Svanberg E, Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients Int J Cancer 2001; 93: 380–383.
8. Xu WP, Cao DX, Lin ZM, Wu GH, Chen L, Zhang JP, Zhang B, Yang ZA, Jiang Y, Han YS, Xu L, Zhu Y, Chen WF. Analysis of energy utilization and body composition in kidney, bladder, and adrenal cancer patients. Urol Oncol 2012; 30: 711–718.
9. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489–495.
10. Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, Antoun S, Baracos VE. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? Am J Clin Nutr. 2013; 98: 1012–1019.
11. Thompson SR, Hirshberg A, Haffejee AA, Huizinga WK. Resting metabolic rate of esophageal carcinoma patients: a model for energy expenditure measurement in a homogenous cancer population. J Parenter Enteral Nutr 1990; 14: 119–121.
12. Dev R, Del Fabbro E, Schwartz GG, Hui D, Palla SL, Gutierrez N, Bruera E. Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist 2011; 16: 1637–1641.
13. Capellino S, Straub RH, Cutolo M. Aromatase and regulation of the estrogen-to-androgen ration in synovial tissue inflammation: common pathway in both sexes. Ann N Y Acad Sci 2014; 1317: 24–31.
14. Wigmore SJ, Falconer JS, Plester CE, Ross JA, Maingay JP, Carter DC, Fearon KC. Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients. Br J Cancer 1995; 72: 185–188.
15. Barber MD, McMillan DC, Preston T, Ross JA, Fearon KC. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci 2000; 98: 389–399.
16. Gambardella A, Tortoriello R, Pesce L, Tagliamonte MR, Paolisso G, Varricchio M. Intralipid infusion combined with propranolol administration has favorable effects in elderly malnourished cancer patients. Metabolism 1999; 48: 291–297.
17. Klein CJ, Stanek GS, Wiles CE 3rd. Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc 1998; 98: 795–806.
18. Cooper DS. Hyperthyroidism. Lancet 2003; 362: 459–468.
19. Reeves MM, Capra S, Bauer J, Davies PS, Battistutta D. Clinical accuracy of the MedGem indirect calorimeter for measuring resting energy expenditure in cancer patients. Eur J Clin Nutr 2005; 59: 602–610.